Andere talen OSL Group Limited

Aandelen

863 KYG1106B1095

Vertraagde tijd Hong Kong S.E. Andere beurzen 05:55:57 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
9,6 ^HKD	-2,04%		-0,83%	-21,05%

19/04	OSL Group Limited kondigt het aftreden aan van Yang Yu als onafhankelijk niet-uitvoerend bestuurder	CI
10/04	OSL wordt gezien als de grootste kanshebber voor de Europese activiteiten van Ted Baker	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

OSL Group Limited Announces the Resignation of Yang Yu as Independent Non-Executive Director	19/04
OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial	18/04
Solowin Unit Chosen as Participating Dealer for Spot Bitcoin, Ethereum ETF in Hong Kong	16/04
OSL Arm to Provide Trading Platform for ChinaAMC's Spot Bitcoin ETFs	16/04
OncoSil Medical Treats First Commercial Patient in Turkey with Implantable Pancreatic Cancer Device	16/04
OSL : Appointed as the First Exchange and Sub-Custodian Partner for China AMC’s Inaugural Spot BTC/ETH ETF Launch in Hong Kong	15/04
OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study	12/04
OSL Said to Be Leading Contender for Ted Baker’s European Business	10/04
OncoSil Medical Obtains Device Reimbursement Approval in UK	09/04
OSL : Monthly Investor Update	05/04
First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device	05/04
OSL Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Oncosil Medical Issues Non-Renounceable Entitlement Offer Prospectus	25/03
Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer	20/03
OSL : Monthly Investor Update	05/03
Hainan Wanruntong Information Technology Co., Ltd announced that it has received funding from HongShan, OSL Group Limited, Animoca Brands Limited	22/02
OSL to Participate in Pilot Investment-Grade Tokenized Warrant Issuance of UBS	07/02
Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade	01/02
OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%	01/02
OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%	01/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen OSL Group Limited

Aandelen

863

KYG1106B1095

Andere talen

Filters